U

|

Tear Osmolarity in the Diagnosis and Management of Dry Eye Disease

February 16 2023

JMICHAEL A. LEMP, ANTHONY J. BRON, CHRISTOPHE BAUDOUIN, JOSÉ M. BENÍTEZ DEL CASTILLO, DAVID GEFFEN, JOE TAUBER, GARY N. FOULKS, JAY S. PEPOSE, AND BENJAMIN D. SULLIVAN

PURPOSE: To evaluate the use of tear osmolarity in the diagnosis of dry eye disease.

DESIGN: A prospective, observational case series to determine the clinical usefulness of tear osmolarity and commonly used objective tests to diagnose dry eye disease.

METHODS: A multicenter, 10-site study consisting of 314 consecutive subjects between 18 and 82 years of age. Bilateral tear osmolarity, tear film break-up time (TBUT), corneal staining, conjunctival staining, Schirmer test, and meibomian gland grading were performed. Diagnostic performance was measured against a composite index of objective measurements that classified subjects as having normal, mild or moderate, or severe dry eye. The main outcome measures were sensitivity, specificity, area under the receiver operating characteristic curve, and intereye variability.

RESULTS: Of the 6 tests, tear osmolarity was found to have superior diagnostic performance. The most sensitive threshold between normal and mild or moderate subjects was found to be 308 mOsms/L, whereas the most specific was found at 315 mOsms/L. At a cutoff of 312 mOsms/L, tear hyperosmolarity exhibited 73% sensitivity and 92% specificity. By contrast, the other common tests exhibited either poor sensitivity (corneal staining, 54%; conjunctival staining, 60%; meibomian gland grading, 61%) or poor specificity (tear film break-up time, 45%; Schirmer test, 51%). Tear osmolarity also had the highest area under the receiver operating characteristic curve (0.89). Intereye differences in osmolarity were found to correlate with increasing disease severity (r2 = 0.32).

CONCLUSIONS: Tear osmolarity is the best single metric both to diagnose and classify dry eye disease. Intereye variability is a characteristic of dry eye not seen in normal subjects.

(Am J Ophthalmol 2011;151:792–798. © 2011 by Elsevier Inc. All rights reserved.)

Discover More Clinicals

Learn more insights and information

Local Contact For More Information

Need additional information about eye care solutions? Get in touch with us today. We will connect you with your local Territory Manager.

Need additional information about eye care solutions? Get in touch with us today. We will connect you with your local Territory Manager.

"*" indicates required fields

Email Communications*

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.